Rapid benefit-risk assessments: No escape from expert judgments in risk management

Risk Analysis

Volumn 26, Issue 1, 2006, Pages 147-156

  Claycamp, H Gregg ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Benefits assessment; Expert judgment; Microbial risk assessment; Policy making; Probalistic risk assessment; Quality adjusted life years

Indexed keywords

DECISION THEORY; HEALTH; IMMUNOLOGY; MEDICAL APPLICATIONS; MICROORGANISMS; RISK ASSESSMENT;

BENEFITS ASSESSMENT; EXPERT JUDGMENT; MICROBIAL RISK ASSESSMENT; POLICY MAKING; PROBALISTIC RISK ASSESSMENT; QUALITY-ADJUSTED LIFE YEARS;

RISK MANAGEMENT;

ANTIINFECTIVE AGENT; ENROFLOXACIN;

POULTRY;

ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CHICKEN; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG USE; MEDICAL DECISION MAKING; MEDICAL EXPERT; PHYSICAL DISEASE; QUALITY ADJUSTED LIFE YEAR; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK MANAGEMENT; STATISTICAL ANALYSIS; SYSTEMIC DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EXPERT TESTIMONY; FOOD CONTAMINATION; FOOD MICROBIOLOGY; HUMANS; RISK ASSESSMENT; RISK MANAGEMENT; VETERINARY DRUGS;

ANIMALIA; GALLUS GALLUS;

EID: 33645103575     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2006.00724.x     Document Type: Review

References (49)

1. Ad Hoc Group on Antimicrobial Resistance 2002 Risk Analysis Methodology for the Potential Impact on Public Health of Antimicrobial Resistant Bacteria of Animal Origin Office International des Epizooties Paris World Organization for Animal Health
2. Anonymous 1996 Principles for Evaluating Epidemiologic Data in Regulatory Risk Assessment Washington DC Federal Focus, Inc
3. Australian Pesticides & Veterinary Medicines Authority 2004 Findings of the Reconsideration of the Registration of Products Containing Virginiamycin, and Their Labels Canberra Australia
4. Barber D. A. Miller G. Y. & McNamara P. E. 2003 Models of antimicrobial resistance and foodborne illness: Examining assumptions and practical applications Journal of Food Protection 66 700 709
5. Barza M. & Travers K. 2002 Excess infections due to antimicrobial resistance: The "attributable fraction Clinical Infectious Diseases 34 Suppl. 3 5126 5130
6. Beers M. H. & Berkow R. 1999 Section 13 infectious diseases 157. Bacterial diseases In The Merck Manual of Diagnosis and Therapy 17th ed. (Centennial Edition) West Point PA Merck and Co
7. Blaser M. J. 2005 Infections due to Campylobacter and related species In Kasper D. L. Fauci A. S. Longo D. L. Braunwald E. Hauser S. L. & Jameson J. L. Eds Harrison's Principles of Internal Medicine 16th ed New York McGraw-Hill, Medical Publishing Division
8. Carnevale R. & Wallinga D. 2004 Point/counterpoint: Does misuse of antibiotics in food animals threaten human health? Alliance for the Prudent Use of Antibiotics (APUA) Newsletter 22 2 4
9. Casman E. A. Ha-Duong M. & Morgan H. G. 2004 Response to Sander Geenland's critique of bounding analysis Risk Analysis 24 1093 1095
10. Chambers H. F. 2004 Infectious diseases: Bacterial & chlamydial In Tierney L. M. Jr. McPhee S. J. & Papadakis M. A. Eds Current Medical Diagnosis & Treatment 43rd ed New York Lange Medical Books/McGraw-Hill Medical Publishing Division
11. Claycamp H. G. 2003 A contemporary approach to risk analysis in GFI #152 FDA Veterinarian 18 2 5 Available at
12. Claycamp H. G. & Hooberman B. H. 2004 Antimicrobial resistance risk assessment for food safety Journal of Food Protection 67 2063 2071
13. Cox L. A. Jr. 2005 Potential human health benefits of antibiotics used in food animals: A case study of virginiamycin Environment International 31 549 563
14. Cox L. A. & Popken D. 2002 A simulation model of human health risks from chicken-borne Campylobacter jejuni Technology 9 55 84
15. Cox L. A. & Popken D. A. 2004a Quantifying human health risks from virginiamycin used in chickens Risk Analysis 24 271 288
16. Cox L. A. & Popken D. A. 2004b Bayesian Monte Carlo uncertainty analysis of human health risks from animal antimicrobial use in a dynamic model of emerging resistance Risk Analysis 24 1153 1164
17. Cox L. A. Jr. & Ricci P. F. 2005 Causation in risk assessment and management: Models, inferences, biases, and a microbial risk-benefit case study Environment International 31 377 397
18. Food and Drug Administration 2001 Risk Assessment on the Human Health Impact of Fluoroquinolone Resistant Campylobacter Associated with the Consumption of Chicken Revised January 5, 2001 FDA Center for Veterinary Medicine Available at Accessed 10 December 2004
19. Food and Drug Administration 2003 Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Guidance for Industry #152, FDA Center for Veterinary Medicine October 23, 2003.
20. Food and Drug Administration 2004a Initial Decision, Docket No. 00N-1571, Proposal to Withdraw Approval of the New Animal Drug Application for Enrofloxacin for Poultry Available at Accessed 01 December 2004
21. Food and Drug Administration 2004b Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals FDA Center for Veterinary Medicine Available at 23, November 2004
22. Food and Drug Administration & U.S. Department of Agriculture 2000a United States Food Safety System Available at Accessed 10 December 2004
23. Food and Drug Administration & U.S. Department of Agriculture 2000b Precaution in U.S. Food Safety Decisionmaking: Annex II to the United States' National Food Safety System Paper Available at Accessed 10 December 2004
24. Goldberg M. B. 2002 IX Infections due to the enteric pathogens Campylobacter, Salmonella, Shigella, Yersinia, Vibrio, and Helicobacter In Dale D. C. & Federman D. D. Eds ACP Medicine (2004) WebMD Publishing Available at
25. Gordis L. 1996 Epidemiology Philadelphia W.B. Saunders
26. Greenland S. 2004 Model-based estimation of relative risks and other epidemiologic measure in studies of common outcomes and in case-control studies American Journal of Epidemiology 160 301 305
27. Greenland S. & Brumback B. 2002 An overview of relations among causal modeling methods International Journal of Epidemiology 31 1030 1037
28. Hammitt J. K. 2002 QALYs versus WTP Risk Analysis 22 985 1001
29. Hill A. B. 1966 The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine 58 295 300
30. Hofstetter P. Bare J. C. Hammitt J. K. Murphy P. A. & Rice G. E. 2002 Tools for comparative analysis of alternative: Competing or complementary perspectives? Risk Analysis 22 833 851
31. Hofstetter P. & Hammitt J. K. 2002 Selecting human health metrics for environmental decision-support tools Risk Analysis 22 965 983
32. Juckett G. 1999 Prevention and treatment of traveler's diarrhea American Family Physician 60 119 124 135 136
33. Kahneman D. Slovic P. & Tversky A. 1982 Judgment under Uncertainty: Heuristics and Biases Cambridge UK Cambridge University Press
34. Lung E. 2003 Acute diarrheal diseases In Friedman S. L. McQuaid K. R. & Grendell J. H. Eds Current Diagnosis & Treatment in Gastroenterology 2nd ed New York Lange Medical Books/McGraw-Hill Medical Publishing Division
35. Matthews R. A. J. 2000 Facts versus factions: The use and abuse of subjectivity in scientific research In Morris J. Ed Rethinking Risk and the Precautionary Principle pp 247 282 Oxford Butterworth Heinemann
36. Morgan M. G. & Henrion M. 1990 Uncertainty Cambridge UK Cambridge University Press
37. National Research Council 1983 Risk Assessment in the Federal Government: Managing the Process Washington DC National Academy Press
38. National Research Council 1996 Understanding Risk: Informing Decisions in a Democratic Society Washington DC National Academy Press
39. Nelson J. M. Smith K. E. Vugia D. J. Rabatsky-Her T. Segler S. D. Kassenborg H. D. Zansky S. M. Joyce K. Marano N. Hoekstra R. M. & Angulo F. J. 2004 Prolonged diarrhea due to ciproflaoxacin-resistant Campylobacter infection Journal of Infectious Diseases 190 1150 1157
40. Pearl J. 2000 Causality Cambridge UK Cambridge University Press
41. Ricci P. F. & Cox L. A. 2002 Empirical causation and biases in epidemiology: Issues and solutions Technology 9 23 54
42. Rothman K. J. & Greenland S. 1998 Modern Epidemiology 2nd ed Philadelphia Lippincott-Raven
43. Ruiz-Palacios G. & Pickering L. K. 2002 Campylobacter In Colin D. Rudolph C. D. Rudolph A. M. Margaret K. Hostetter M. K. Lister G. & Siegel N. J. Eds Rudolph's Pediatrics 21st ed New York McGraw-Hill Medical Publishing Division
44. Salisbury J. G. Nicholls T. J. Lammerding A. M. Turnidge J. & Nunn M. J. 2002 A risk analysis framework for the long-term management of antibiotic resistance in food animals International Journal of Antimicrobial Agents 20 153 164
45. Stanovich K. E. 2003 The fundamental computational biases of human cognition. Heuristics that (sometimes) impair decision making and problem solving In Davidson J. E. & Sternberg R. J. Eds The Psychology of Problem Solving pp 291 342 Cambridge UK Cambridge University Press
46. Tollefson L. & Karp B. E. 2004 Human health impact from antimicrobial use in food animals Médecine et maladies Infectieuses 34 514 521
47. Vose D. Acar J. Anthony F. Franklin A. Gupta R. Nicholls T. Tamura Y. Thompson S. Threfall E. J. van Vuuren M. White D. G. Wegener H. C. & Costarrica M. L. 2001 Antimicrobial resistance: Risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin Revue scientifique et technique, Office International des Épizooties 20 811 827
48. Walker V. R. 2000 Risk regulation and the "faces" of uncertainty Risk: Health, Safety and Environment 9 27 38
49. World Health Organization 2003 Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific Assessment Geneva December 1-5, 2003